 Niranjan Manoharan
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Retinopathy | 5 | 2023 | 149 | 3.030 |
Why?
| | Retinal Detachment | 3 | 2022 | 53 | 1.560 |
Why?
| | Vitreoretinopathy, Proliferative | 2 | 2022 | 10 | 1.500 |
Why?
| | Vitreous Body | 4 | 2022 | 101 | 1.140 |
Why?
| | Macular Degeneration | 5 | 2023 | 152 | 0.920 |
Why?
| | Cataract | 2 | 2023 | 185 | 0.860 |
Why?
| | Macular Edema | 1 | 2023 | 34 | 0.860 |
Why?
| | Insulins | 1 | 2023 | 32 | 0.840 |
Why?
| | Vitreous Detachment | 1 | 2022 | 5 | 0.840 |
Why?
| | Retinal Diseases | 1 | 2023 | 76 | 0.830 |
Why?
| | Ophthalmology | 1 | 2023 | 77 | 0.810 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2094 | 0.700 |
Why?
| | Lens Implantation, Intraocular | 2 | 2018 | 57 | 0.620 |
Why?
| | Geographic Atrophy | 3 | 2023 | 49 | 0.610 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2018 | 16 | 0.600 |
Why?
| | Complement System Proteins | 2 | 2020 | 283 | 0.580 |
Why?
| | Glaucoma, Open-Angle | 1 | 2018 | 95 | 0.540 |
Why?
| | Phacoemulsification | 1 | 2018 | 107 | 0.530 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 900 | 0.500 |
Why?
| | Vitrectomy | 3 | 2022 | 57 | 0.410 |
Why?
| | Visual Acuity | 8 | 2023 | 274 | 0.410 |
Why?
| | Epiretinal Membrane | 2 | 2020 | 6 | 0.360 |
Why?
| | Retinal Perforations | 2 | 2020 | 12 | 0.360 |
Why?
| | Retrospective Studies | 8 | 2023 | 12546 | 0.310 |
Why?
| | Hospitals, County | 1 | 2023 | 10 | 0.220 |
Why?
| | Scleral Buckling | 1 | 2022 | 18 | 0.210 |
Why?
| | Retinal Vein Occlusion | 1 | 2022 | 13 | 0.200 |
Why?
| | Retinal Vein | 1 | 2022 | 13 | 0.200 |
Why?
| | Cluster Analysis | 1 | 2023 | 455 | 0.200 |
Why?
| | Humans | 18 | 2023 | 114662 | 0.190 |
Why?
| | Complement Factor B | 1 | 2022 | 100 | 0.190 |
Why?
| | Retinoschisis | 1 | 2020 | 2 | 0.180 |
Why?
| | Nanopores | 1 | 2020 | 4 | 0.180 |
Why?
| | Retina | 1 | 2022 | 263 | 0.180 |
Why?
| | Membranes, Artificial | 1 | 2020 | 65 | 0.170 |
Why?
| | Nanotechnology | 1 | 2020 | 113 | 0.160 |
Why?
| | Intraocular Pressure | 2 | 2018 | 276 | 0.160 |
Why?
| | Internet | 1 | 2023 | 596 | 0.160 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 11 | 0.150 |
Why?
| | Axial Length, Eye | 1 | 2018 | 9 | 0.150 |
Why?
| | Fluorescein Angiography | 3 | 2023 | 102 | 0.150 |
Why?
| | Corneal Pachymetry | 1 | 2018 | 14 | 0.150 |
Why?
| | Exfoliation Syndrome | 1 | 2018 | 10 | 0.150 |
Why?
| | Pseudophakia | 1 | 2018 | 11 | 0.150 |
Why?
| | Refraction, Ocular | 1 | 2018 | 30 | 0.150 |
Why?
| | Aged, 80 and over | 2 | 2019 | 6345 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 797 | 0.140 |
Why?
| | Trabeculectomy | 1 | 2018 | 65 | 0.140 |
Why?
| | Middle Aged | 5 | 2022 | 26733 | 0.140 |
Why?
| | Biomarkers | 3 | 2023 | 3408 | 0.140 |
Why?
| | Tomography, Optical Coherence | 3 | 2022 | 130 | 0.130 |
Why?
| | Lenses, Intraocular | 1 | 1996 | 42 | 0.130 |
Why?
| | Female | 8 | 2023 | 59493 | 0.120 |
Why?
| | Metabolomics | 1 | 2018 | 521 | 0.110 |
Why?
| | Glaucoma | 1 | 1996 | 202 | 0.110 |
Why?
| | Aged | 4 | 2019 | 19069 | 0.100 |
Why?
| | Risk Factors | 2 | 2023 | 8632 | 0.100 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2012 | 13 | 0.100 |
Why?
| | Intracellular Space | 1 | 2012 | 68 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2012 | 79 | 0.100 |
Why?
| | Protein Multimerization | 1 | 2012 | 157 | 0.090 |
Why?
| | Cell Communication | 1 | 2012 | 279 | 0.090 |
Why?
| | Male | 6 | 2023 | 55583 | 0.080 |
Why?
| | Cataract Extraction | 2 | 1998 | 76 | 0.060 |
Why?
| | Young Adult | 1 | 2019 | 10466 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4411 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2023 | 45 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2023 | 206 | 0.050 |
Why?
| | Complement Factor I | 1 | 2022 | 12 | 0.050 |
Why?
| | Adult | 3 | 2019 | 30544 | 0.050 |
Why?
| | Adolescent | 1 | 2019 | 17841 | 0.050 |
Why?
| | Vision Disorders | 1 | 2022 | 130 | 0.050 |
Why?
| | Fibrinogen | 1 | 2022 | 154 | 0.050 |
Why?
| | Dialysis | 1 | 2020 | 17 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 220 | 0.040 |
Why?
| | Adsorption | 1 | 2020 | 119 | 0.040 |
Why?
| | Rabbits | 1 | 2020 | 733 | 0.040 |
Why?
| | Xanthine | 1 | 2018 | 7 | 0.040 |
Why?
| | Purines | 1 | 2018 | 159 | 0.040 |
Why?
| | Mental Health | 1 | 2022 | 562 | 0.040 |
Why?
| | Intraoperative Complications | 1 | 1998 | 122 | 0.030 |
Why?
| | Postoperative Complications | 2 | 1998 | 2128 | 0.030 |
Why?
| | Polymers | 1 | 2020 | 448 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 282 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2018 | 633 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 1889 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 2796 | 0.030 |
Why?
| | Glucose | 1 | 2018 | 896 | 0.030 |
Why?
| | Inflammation | 1 | 2023 | 2478 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2018 | 1076 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2353 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2012 | 101 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4622 | 0.020 |
Why?
| | Prognosis | 1 | 1996 | 3329 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2012 | 2568 | 0.020 |
Why?
| | Animals | 2 | 2020 | 31699 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 3885 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 4512 | 0.010 |
Why?
| | Eyeglasses | 1 | 1998 | 4 | 0.010 |
Why?
| | India | 1 | 1998 | 134 | 0.010 |
Why?
| | Mice | 1 | 2012 | 14863 | 0.010 |
Why?
| | Safety | 1 | 1998 | 297 | 0.010 |
Why?
| | Incidence | 1 | 1998 | 2313 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1998 | 9088 | 0.000 |
Why?
|
|
Manoharan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|